Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial
Launched by SOUTHERN MEDICAL UNIVERSITY, CHINA · Nov 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help doctors improve their skills in treating common children's illnesses, such as pneumonia, rotavirus infection, hand-foot-and-mouth disease, appendicitis, and respiratory failure. Researchers are using a virtual platform that simulates real-life patient cases to train doctors. This method uses artificial intelligence to create virtual patients that can help doctors practice and enhance their understanding of these conditions. The goal is to see if this type of training is more effective than traditional methods, like teaching manuals or videos.
Doctors from various healthcare facilities across China will be invited to participate in the trial. Eligible participants include practicing doctors and rural doctors who work in primary or secondary hospitals, community health centers, and clinics. During the study, participants will spend two weeks learning using the virtual platform, after which their ability to follow best practices in treating these illnesses will be tested. This trial aims to improve pediatric healthcare, especially in areas where resources are limited, ultimately benefiting children and their families.
Gender
ALL
Eligibility criteria
- • 1. Inclusion and Exclusion Criteria for Research Institutions
- Inclusion Criteria:
- • Primary and secondary hospitals
- • Community health centers (stations) and clinics, as well as township health centers and village health clinics
- Exclusion Criteria:
- • Specialized medical institutions (such as specialized hospitals and dental clinics)
- • Public health prevention and treatment institutions (such as tuberculosis prevention centers)
- • Ethnic medicine institutions (such as Mongolian and Tibetan hospitals)
- • Hospitals above the secondary level
- • Hospitals that have not yet been graded (due to their short establishment time and potentially unstable operations)
- • 2. Inclusion and exclusion criteria for research subjects
- Inclusion Criteria:
- • Practicing (assistant) doctors and rural doctors working in medical institutions that meet the above conditions
- • With a scope of practice only including general practice, internal medicine, surgery, and pediatrics
- Exclusion Criteria:
- • -None
About Southern Medical University, China
Southern Medical University, located in Guangzhou, China, is a leading institution in medical research and education, renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong focus on translational medicine, the university collaborates with various healthcare institutions and industry partners to conduct rigorous research aimed at improving patient outcomes and developing new therapeutic strategies. Its state-of-the-art facilities and a diverse team of experienced researchers enable Southern Medical University to contribute significantly to the global medical research landscape, particularly in areas such as pharmacology, infectious diseases, and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guiyang, Guizhou, China
Fuzhou, Jiangxi, China
Honghe, Yunnan, China
Patients applied
Trial Officials
Yao Zhao, Doctor
Principal Investigator
National Clinical Research Center for Child Health and Disorders, Chongqing, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported